Targeting KIF20A Kinesin: A Promising Strategy for Next-Generation ADC Payload

Time: 11:45 am
day: Conference Day Two


  • Presenting EVX-020, a first-in-class highly selective KIF20A inhibitor
  • Sharing nonclinical efficacy data of EVX-020 in tumor models and the involvement of KIF20A in Golgi Function
  • Analyzing the MoA of EVX-020, and its potential as a new ADC payload